Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced that effective January 1, 2012, it has entered into a new Master Agreement to provide diagnostic laboratory services for some of the facilities that Corizon, Inc. services around the country providing contract healthcare services to state and local prisons. Corizon was formed during 2011 as a result of the merger of Prison Healthcare Services (“PHS”) and Correctional Medical Services (“CMS”), two of the largest prison healthcare providers in the country. Prior to the merger, BioReference was a preferred provider for both PHS and CMS. The new contract is expected to represent about $18,000,000 in business to BRLI over the next year based on continued business at facilities being currently served by the Company. The contract has a one-year term with one-year optional renewal terms, subject to termination by the parties in accordance with the agreement. BRLI began service to the predecessor businesses more than a decade ago and has continually increased its business with the predecessors and current company over time.
Marc D. Grodman, MD, CEO of BRLI, commented: “We have a long and valuable relationship with the teams at Corizon and we appreciate the continued relationship that this contract will provide. BRLI has developed unique informatics and service solutions for Corizon and we will continue to work with them to increase and improve efficiency in the operations covered under this contract. We look forward to a long and growing relationship with Corizon.”
About BioReference Laboratories, Inc .
BRLI is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. We believe that we are the fourth largest full-service laboratory in the United States and the largest independent regional laboratory in the Northeastern market. BRLI offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. BRLI primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, women’s health and correctional health care.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV